Edition:
United Kingdom

People: Johnson & Johnson (JNJ.N)

JNJ.N on New York Stock Exchange

131.36USD
16 Aug 2019
Change (% chg)

$0.82 (+0.63%)
Prev Close
$130.54
Open
$131.61
Day's High
$131.65
Day's Low
$130.61
Volume
1,792,996
Avg. Vol
2,050,461
52-wk High
$148.97
52-wk Low
$122.00

McClellan, Mark 

Dr. Mark B. McClellan, M.D., Ph.D. is an Independent Director of the Company. He became the inaugural Director of the Duke-Robert J. Margolis, MD, Center for Health Policy and the Margolis Professor of Business, Medicine and Policy at Duke University in January 2016. He is also a faculty member at Dell Medical School at The University of Texas in Austin. Previously, he served from 2007 to 2015 as a Senior Fellow in Economic Studies and as Director of the Initiatives on Value and Innovation in Health Care at the Brookings Institution. Dr. McClellan served as Administrator of the Centers for Medicare & Medicaid Services for the U.S. Department of Health and Human Services from 2004 to 2006 and as Commissioner of the U.S. Food and Drug Administration from 2002 to 2004. He served as a member of the President’s Council of Economic Advisers and as senior director for healthcare policy at the White House from 2001 to 2002 and, during President Bill Clinton’s administration, held the position of Deputy Assistant Secretary for Economic Policy for the Department of the Treasury. Dr. McClellan previously served as an associate professor of economics and medicine with tenure at Stanford University, where he also directed the Program on Health Outcomes Research. Dr. McClellan is the founding chair and a current board member of the Reagan-Udall Foundation for the Food and Drug Administration, is a member of the National Academy of Medicine and chairs the Academy’s Leadership Consortium for Value and Science-Driven Health Care, and co-chairs the guiding committee of the Health Care Payment Learning and Action Network.

Basic Compensation

Total Annual Compensation, USD 115,000
Restricted Stock Award, USD 184,940
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 299,940

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Alex Gorsky

20,097,600

Paulus Stoffels

10,591,800

Joaquin Duato

9,283,960

Joseph Wolk

2,708,190

Peter Fasolo

3,621,280

Michael Ullmann

5,336,150
As Of  31 Dec 2018